A meta-analysis of the relationship between lymphatic microvessel density and the survival of patient with colorectal cancer

Lymphology

Volumn 46, Issue 1, 2013, Pages 42-51

  Chen, Y ^a   Yan, J ^a   Wang, Z ^a   Yu, S ^a   Yuan, Z ^a   Yang, C ^a   Zheng, Q ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; Lymphangiogenesis; Lymphatic microvessel density; Prognosis; Survival

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CAPILLARY DENSITY; COLORECTAL CANCER; DISEASE FREE SURVIVAL; HUMAN; LYMPH VESSEL; LYMPHATIC MICROVESSEL DENSITY; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

COLORECTAL NEOPLASMS; HUMANS; LYMPHATIC VESSELS; MICROVESSELS; SURVIVAL RATE;

EID: 84880749963     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Jemal, A, R Siegel, E Ward, et al: Cancer statistics, 2009. CA Cancer J. Clin. 59 (2009), 225-249.
2. Sundlisaeter, E, A Dicko, PO Sakariassen, et al: Lymphangiogenesis in colorectal cancer-prognostic and therapeutic aspects. Int. J. Cancer 121 (2007), 1401-1409.
3. Pang, R, WL Law, AC Chu, et al: A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell. Stem Cell 6 (2010), 603-615.
4. Gao, J, A Knutsen, G Arbman, et al: Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig. Liver Dis. 41 (2009), 116-122.
5. Pepper, MS: Lymphangiogenesis and tumor metastasis: Myth or reality? Clin. Cancer Res. 7 (2001), 462-468.
6. Da, MX, Z Wu, HW Tian: Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch. Med. Res. 39 (2008), 365-372.
7. Sleeman, J, A Schmid, W Thiele: Tumor lymphatics. Semin. Cancer Biol. 19 (2009), 285-297.
8. Moreira, LR, AA Schenka, P Latuf-Filho, et al: Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors. Tumour Biol. 32 (2011), 527-534.
9. Chung, DC: Molecular prognostic markers and colorectal cancer: The search goes on. Gastroenterology 114(1998), 1330-1332.
10. Nathanson, SD: Insights into the mechanisms of lymph node metastasis. Cancer 98 (2003), 413-423.
11. Des Guetz, G, B Uzzan, P Nicolas, et al: Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br. J. Cancer 94 (2006), 1823-1832.
12. Koh, YJ, HZ Kim, SI Hwang, et al: Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage. Cancer Cell 18 (2010), 171-184.
13. Eskens, F: Critical assessment of angiogenesis inhibitors in clinical trials. Suppl. Tumori 1 (2002), S12-S13.
14. Chu, AY, LA Litzky, TL Pasha, et al: Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod. Pathol. 18(2005), 105-110.
15. He, Y, T Karpanen, K Alitalo: Role of lymphangiogenic factors in tumor metastasis. Biochem. Biophys. Acta 1654 (2004), 3-12.
16. Harrell, MI, BM Iritani, A Ruddell: Tumor- induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 170 (2007), 774- 786.
17. Choi, WW, MM Lewis, D Lawson, et al: Angiogenic and lymphangiogenic microvessel density in breast carcinoma: Correlation with clinicopathologic parameters and VEGF- family gene expression. Mod. Pathol. 18, 143-152.
18. Vieira, SC, BB Silva, GA Pinto, et al: CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathol. Res. Pract. 201 (2005), 313-318.
19. Omachi, T, Y Kawai, R Mizuno, et al: Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance. Cancer Lett. 246 (2007), 167-172.
20. Saad, RS, L Kordunsky, YL Liu, et al: Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod. Pathol. 19, 1317-1323.
21. Holmqvist, A, J Gao, G Adell, et al: The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy. Ann. Oncol. 21 (2009), 512-517.
22. Matsumoto, K, Y Nakayama, Y Inoue, et al: Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis. Colon Rectum 50 (2007), 308-314.
23. Kaneko, I, S Tanaka, S Oka, et al: Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J. Gastroenterol. 13 (2007), 3829-3835.
24. Wells, GA, B Shea, D O'Connell, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
25. Parmar, MK, V Torri, L Stewart: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat. Med. 17 (1998), 2815-2834.
26. Tierney, JF, LA Stewart, D Ghersi, et al: Practical methods for incorporating summary time-to-event data into meta- analysis. Trials 8 (2007), 16.
27. Yusuf, S, R Peto, J Lewis, et al: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog. Cardiovasc. Dis. 27 (1985), 335-371.
28. Begg, CB, M Mazumdar: Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088-1101.
29. Egger, M, G Davey Smith, M Schneider, et al: Bias in meta- analysis detected by a simple, graphical test. BMJ 315 (1997), 629-634.
30. Spruance, SL, JE Reid, M Grace, et al: Hazard ratio in clinical trials. Antimicrob. Agents Chemother. 48 (2004), 2787-2792.
31. Meert, AP, M Paesmans, B Martin, et al: The role of microvessel density on the survival of patients with lung cancer: A systematic review of the literature with meta- analysis. Br. J. Cancer 87 (2002), 694-701.
32. Chen, W, Li Y, Liao Z, et al: Active lymphangiogenesis is a major risk factor for anastomotic leakage following sphincter- sparing resection of rectal cancer. J. Surg. Oncol. 104 (2011), 493-498.
33. Yang, X, LR Li, ZZ Pan, et al: (Lymphatic vessel density in Dukes' B rectal carcinoma and its correlation to prognosis). Ai Zheng 26 (2006), 749-752.
34. Fan, YZ, GM Li, GP Huang, et al: (Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma). Zhonghua Wei Chang Wai Ke Za Zhi 9 (2006), 477-482.
35. Mou, JH, XC Yan, ZP Li, et al: (Characteristic and clinicopathologic significance of lymphan-giogenesis in colorectal cancer). Zhonghua Bing Li Xue Za Zhi 34 (2005), 348-352.
36. Li, ZX, GF Zhang, ZQ Hu, et al: (Expression of lymphatic vessel endothelial hyaluronan receptor-1 in human colorectal cancer and its clinical significance). Zhonghua Wei Chang Wai Ke Za Zhi 12 (2009), 511-514.
37. Wang, TB, YH Huang, P Lan, et al: (Correlation of lymphangiogenesis to progression of colorectal cancer). Ai Zheng 24 (2005), 1276-1279.
38. Jiang, JB, XM Li, WD Zhang, et al: (Relationship of vascular endothelial growth factor-C and lymphangiogenesis with the development and prognosis of colon cancer). Zhonghua Wei Chang Wai Ke Za Zhi 8 (2005), 516-519.
39. Barresi, V, L Reggiani-Bonetti, C Di Gregorio, et al: Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J. Clin. Pathol. 64 (2011), 6-12.
40. Lin, M, SP Ma, HZ Lin, et al: Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin. Exp. Metastasis 27 (2010), 123-132.
41. Yan, G, XY Zhou, SJ Cai, et al: Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World J. Gastroenterol 14 (2008), 101- 107.
42. Barresi, V, L Reggiani Bonetti, E Vitarelli, et al: Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: Prognostic relevance and correlation with nodal micrometastases. Am. J. Surg. Pathol. 36 (2012), 66-72.
43. Doekhie, FS, H Morreau, GH de Bock, et al: Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence. Cancer Microenviron. 1 (2008), 141-151.
44. Algars, A, H Irjala, S Vaittinen, et al: Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int. J. Cancer 131 (2012), 864-873.
45. Liang, P, JW Hong, H Ubukata, et al: Increased density and diameter of lymphatic microvessels correlate with lymph node metastasis in early stage invasive colorectal carcinoma. Virchows Arch. 448 (2006), 570-575.
46. Kaneko, I, S Tanaka, S Oka, et al: Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer. Dis. Colon Rectum 50 (2007), 13-21.
47. Liang, P, JW Hong, H Ubukata, et al: Myofibroblasts correlate with lymphatic microvessel density and lymph node metastasis in early-stage invasive colorectal carcinoma. Anticancer Res. 25 (2005), 2705-2712.
48. Yoo, PS, AL Mulkeen, A Dardik, et al: A novel in vitro model of lymphatic metastasis from colorectal cancer. J. Surg. Res. 143 (2007), 94-98.
49. Tsirlis, TD, G Papastratis, K Masselou, et al: Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J. Gastroenterol. 14 (2008), 2691-2701.
50. Saharinen, P, T Tammela, MJ Karkkainen, et al: Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 25 (2004), 387-395.
51. Royston, D, DG Jackson: Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J.Pathol. 217(2009), 608-619.
52. Jia Y, Liu M, Huang W, et al: Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer. Pathol. Oncol. Res. 18 (2012), 315-323.
53. Thiele, W, JP Sleeman: Tumor-induced lymphangiogenesis: A target for cancer therapy? J. Biotechnol. 124 (2006), 224- 241.
54. Jussila, L, K Alitalo: Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82 (2002), 673-700.
55. Lu, Y, Q Yang, Y Du, et al: Expression analysis of lymphangiogenic factors in human colorectal cancer with quantitative RT-PCR. Cancer Invest. 25 (2007), 393-396.
56. Sundlisaeter, E, GV Rosland, JK Hertel, et al: Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF-2 is downregulated in tumor tissue compared with normal mucosa. Acta Pathol. Microbiol. Immunol. Scand. 117 (2009), 212-221.
57. Gao, Y, WX Zhong, DB Mu, et al: Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors. Ann. Surg. Oncol. 15 (2008), 1117-1123.
58. Moreira, LR, AA Schenka, PL Filho, et al: Comparison of blood neoangiogenesis and lymphatic vascularization in colorectal adenomas from patients with and without concomitant colorectal cancer. Braz. J. Med. Biol. Res. 42 (2009), 593-598.
59. Gao, F, YM Lu, ML Cao, et al: Expression and quantification of LYVE-1 in human colorectal cancer. Clin. Exp. Med. 6 (2006), 65-71.
60. Kenney, BC, D Jain: Identification of lymphatics within the colonic lamina propria in inflammation and neoplasia using the monoclonal antibody D2-40. Yale J. Biol. Med. 81 (2008), 103-113.
61. Duff, SE, M Jeziorska, S Kumar, et al: ' Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Dis. 9 (2007), 793-800.
62. Longatto-Filho, A, C Pinheiro, L Ferreira, et al: Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Arch. 452 (2008), 133-138.
63. Chen, W, W Shen, M Chen, et al: Study on the relationship between lymphatic vessel density and distal intramural spread of rectal cancer. Eur. Surg. Res. 39 (2007), 332-339.
64. Chen, W, M Chen, Z Liao, et al: Lymphatic vessel density as predictive marker for the local recurrence of rectal cancer. Dis. Colon Rectum 52 (2009), 513-519.
65. Noda, E, K Maeda, T Inoue, et al: Predictive value of vascular endothelial growth factor-C expression for local recurrence of rectal carcinoma. Oncol. Rep. 17 (2007), 1327- 1331.
66. Zhong, D, Y Li, Q Peng, et al: Expression of Tiaml and VEGF- C correlates with lymphan-giogenesis in human colorectal carcinoma. Cancer Biol. Ther. 8 (2009), 689-695.
67. Du, B, ZY Yang, XY Zhong, et al: Metastasis- associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World J. Gastroenterol. 17 (2011), 1219-1226.
68. Naik, VR, H Jaafar, CE Seng: Lymphatic channel density in colorectal adenocarcinoma. Indian J. Pathol. Microbiol. 53 (2010), 12-14.
69. Levin, B, DA Lieberman, B McFarland, et al: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi- Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008), 1570-1595.
70. Weitz, J, M Koch, J Debus, et al: Colorectal cancer. Lancet 365 (2005), 153-165.
71. Juni, P, DG Altman, M Egger: Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 323 (2001), 42-46.
72. Schoenleber, SJ, DM Kurtz, JA Talwalkar, et al: Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. Br. J. Cancer 100 (2009), 1385-1392.